Reuters - Wyeth on Wednesday said
second-quarter earnings fell 7 percent, hurt by generic forms
of its Protonix ulcer drug, although results beat estimates as
they were helped by its vaccine for childhood infections and a
drug for inflammatory disease.
Yahoo! News: Earnings News
